![ANQUR: A new clinical trial in the UK for MND](https://mndresearch.blog/wp-content/uploads/2023/09/Gene-therapy-pic-809x634.png)
ANQUR: A new clinical trial in the UK for MND
Reading Time: 6 minutes QurAlis, a biotechnology company focused on developing precision medicines for MND and other neurodegenerative diseases, has announced the opening of a clinical trial in the UK. This trial of a gene therapy, called QRL-201, is a phase 1 trial in people with MND and will test the therapy to determine whether it is safe and…